Shin-Ichi Kitagawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shin-Ichi Kitagawa has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Isao Miyashiro
Cancer Control Center, Osaka International Cancer Institute
1 shared publicationKazuhiro Tani
Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan
1 shared publicationKyoichi Inoue
The Third Department of Internal Medicine (K. Tani, Y. Kubota, T. Yamaguchi, S. Kitagawa, T. Seki, T. Mizuno, and K. Inoue), and the Department of Radiology (T. Katoh), Kansai Medical University, Osaka, Japan
1 shared publicationLing Zha
Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University
1 shared publicationTakako Mizuno
The Third Department of Internal Medicine (K. Tani, Y. Kubota, T. Yamaguchi, S. Kitagawa, T. Seki, T. Mizuno, and K. Inoue), and the Department of Radiology (T. Katoh), Kansai Medical University, Osaka, Japan
1 shared publication- Takashi Yamaguchi
Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka 573-1191, Japan
1 shared publication
Latest Publications
- Open Access
- 5 November 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (11) , 505-514
Suicide Risk Among Patients With Cancer by Sex in Japan: A Population-based Study
Background: In Japan, few studies have examined suicide risk for five-year relative survival rates for cancer sites. Since five-year relative survival rates differ by sex, we aim to examine suicide risk for patients with cancer separately for men and women.Methods: We estimated the risk of suicide among patients with cancer by sex in Japan compared to the general population, using standardized mortality ratios (SMRs). Patients with cancer diagnosed between January 1, 1985–December 31, 2013 and registered in the Osaka Cancer Registry were followed-up with for up to 10 years. The outcome was suicide death. In addition, cancer sites were classified into three prognosis groups based on five-year relative survival rates: good (> 70%), moderate (40–70%), poor (< 40%).Results: Among 623 995 patients with cancer observed for 2 349 432 person-years, 1210 patients died by suicide (867 men and 343 women). The SMRs were almost equal for men (1.66, 95% CI, 1.55-1.77) and women (1.65, 95% CI, 1.48-1.83). SMRs for cancer prognosis groups were 1.01 (95% CI, 0.84-1.22) for men and 1.47 (95% CI, 1.24-1.73) for women in the good group, 1.53 (95% CI, 1.39-1.68) for men and 1.74 (95% CI, 1.47-2.05) for women in the moderate group, and 2.54 (95% CI, 2.27-2.85) for men and 1.87 (95% CI, 1.43-2.46) for women in the poor group.Conclusions: In this population, both sexes had higher suicide risk with poor prognosis, but the difference in SMRs between the good and poor groups was smaller for women than men.
- 5 November 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (11) , 505-514
Open AccessSuicide Risk Among Patients With Cancer by Sex in Japan: A Population-based Study
Background: In Japan, few studies have examined suicide risk for five-year relative survival rates for cancer sites. Since five-year relative survival rates differ by sex, we aim to examine suicide risk for patients with cancer separately for men and women.Methods: We estimated the risk of suicide among patients with cancer by sex in Japan compared to the general population, using standardized mortality ratios (SMRs). Patients with cancer diagnosed between January 1, 1985–December 31, 2013 and registered in the Osaka Cancer Registry were followed-up with for up to 10 years. The outcome was suicide death. In addition, cancer sites were classified into three prognosis groups based on five-year relative survival rates: good (> 70%), moderate (40–70%), poor (< 40%).Results: Among 623 995 patients with cancer observed for 2 349 432 person-years, 1210 patients died by suicide (867 men and 343 women). The SMRs were almost equal for men (1.66, 95% CI, 1.55-1.77) and women (1.65, 95% CI, 1.48-1.83). SMRs for cancer prognosis groups were 1.01 (95% CI, 0.84-1.22) for men and 1.47 (95% CI, 1.24-1.73) for women in the good group, 1.53 (95% CI, 1.39-1.68) for men and 1.74 (95% CI, 1.47-2.05) for women in the moderate group, and 2.54 (95% CI, 2.27-2.85) for men and 1.87 (95% CI, 1.43-2.46) for women in the poor group.Conclusions: In this population, both sexes had higher suicide risk with poor prognosis, but the difference in SMRs between the good and poor groups was smaller for women than men.
- 1 November 1991
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 15 (6) , 975-978
MR Imaging of Peripheral Cholangiocarcinoma
A prospective study was performed to compare MR spin-echo (SE) sequences [repetition time/echo time (TR/TE) 2,000/80, 500/44 ms], unenhanced CT, and rapid intravenous contrast enhanced CT in eight consecutive patients with peripheral cholangiocarcinoma. All the tumors (ranging from 5 to 9.6 cm in size) were detected with all four techniques. Tumor contrast, however, was qualitatively greatest on long TR/TE SE images. With long TR/TE SE images, tumors were demonstrated as well-demarcated homogeneous regions of high signal intensity, and the anatomic relations between tumors and intrahepatic blood vessels were easily perceived. Detection of small intrahepatic metastatic foci was best on long TR/TE images. Tumor invasion of the portal vein's branches was also best seen on long TR/TE SE images. These results indicate that long TR/TE SE sequence is the most effective initial screening method in demonstrating the presence and determining resectability of peripheral cholangiocarcinoma.
- 1 November 1991
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 15 (6) , 975-978
MR Imaging of Peripheral Cholangiocarcinoma
A prospective study was performed to compare MR spin-echo (SE) sequences [repetition time/echo time (TR/TE) 2,000/80, 500/44 ms], unenhanced CT, and rapid intravenous contrast enhanced CT in eight consecutive patients with peripheral cholangiocarcinoma. All the tumors (ranging from 5 to 9.6 cm in size) were detected with all four techniques. Tumor contrast, however, was qualitatively greatest on long TR/TE SE images. With long TR/TE SE images, tumors were demonstrated as well-demarcated homogeneous regions of high signal intensity, and the anatomic relations between tumors and intrahepatic blood vessels were easily perceived. Detection of small intrahepatic metastatic foci was best on long TR/TE images. Tumor invasion of the portal vein's branches was also best seen on long TR/TE SE images. These results indicate that long TR/TE SE sequence is the most effective initial screening method in demonstrating the presence and determining resectability of peripheral cholangiocarcinoma.